Search Within

Gilles Andre Salles

Formats
  1. Meeting Abstract (181)
  2. Journal Article (74)
  3. Research Letter (18)
  4. Review (17)
  5. Editorial (5)
  6. Correspondence (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Section (1)
Groups
  1. Department of Medicine (303)
  2. Hematologic Malignancies, Division of (303)
  3. Center for Hematologic Malignancies (163)
  4. Lymphoma (159)
  5. Survivorship Research (115)
  6. Graduate Medical Education (106)

More Groups

People
  1. Maria Palomba (108)
  2. Andrew Zelenetz (74)
  3. Lorenzo Falchi (64)
  4. Anita Kumar (63)
  5. Gunjan Shah (61)
  6. Miguel-Angel Perales (59)

More People

Years
  1. 2025 (20)
  2. 2024 (67)
  3. 2023 (97)
  4. 2022 (69)
  5. 2021 (44)
  6. 2020 (6)
Publications
  1. Blood (126)
  2. Hematological Oncology (28)
  3. Journal of Clinical Oncology (17)
  4. Blood Advances (16)
  5. Haematologica (14)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (143)
  2. Wiley Blackwell (30)
  3. Elsevier Inc. (20)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (14)
  6. Nature Publishing Group (14)

More Publishers

Results (303)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcome in multiple myeloma patients treated in the era of modern therapies who were admitted to intensive care: A retrospective analysis from a teaching hospital between 2014 and 2019
    Meeting Abstract

    Gross, Z.; Idlhaj, M.; Karlin, L.; Friggeri, A.; Lazareth, A.; Golfier, C.; Lequeu, H.; Sauvy, F. B.; Sesques, P.; Safar, V.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Severe persistent cytopenias following CAR T-cell therapy in patients with large B-cell lymphoma
    Meeting Abstract

    De Lapuerta, M. C.; Shouval, R.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Batlevi, C. L.; Fein, J. A.; Giralt, S. A.; Lin, R. J.; Nath, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Indirect comparisons of the efficacy of subcutaneous epcoritamab vs chemoimmunotherapy in patients with relapsed or refractory large B-cell lymphoma
    Meeting Abstract

    Salles, G.; Wang, A.; Mutebi, A.; Alshreef, A.; Davies, K. R.; van de Wetering, G.; Chirikov, V.
    Blood (2022)

    Fulltext@MSK | Save
  • A comparison of overall survival with brexucabtagene autoleucel (brexu-cel) CAR T-cell therapy (ZUMA-2) and standard of care (SCHOLAR-2) in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) previously treated with a covalent bruton tyrosine kinase inhibitor (BTKi)
    Meeting Abstract

    Hess, G.; Dreyling, M.; Oberic, L.; Gine, E.; Zinzani, P. L.; Linton, K. M.; Vilmar, A.; Jerkeman, M.; Chen, J. M. H.; Ohler, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Final results of a phase Ib/II randomized study and single-arm extension (Ext) study
    Meeting Abstract

    Sehn, L. H.; Hertzberg, M.; Opat, S.; Herrera, A. F.; Assouline, S.; Flowers, C. R.; Kim, T. M.; McMillan, A. K.; OĢˆzcan, M.; Safar, V.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation
    Meeting Abstract

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition
    Meeting Abstract

    Grilo, A. M.; Klaus, C.; McDonald, A.; Gollob, J.; Weiss, M.; O'Connor, O. A.; Salles, G.; Chaudhuri, J.; Lue, J. K.
    Blood (2022)

    Fulltext@MSK | Save